🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Single arm- subject treated with Tegoprubart and everolimus. The purpose o...
Status
Recruiting
Location
Diabetes Research Institute, University of Miami
Start Date
2027-04-29
Trial ID
NCT07592000
Treatments Being Tested
This is an open-label, single-institution study to assess the safety and th...
Status
Recruiting
Location
Massachusetts General Hospital
Start Date
2025-05-31
Trial ID
NCT06972069
This study will evaluate the safety and efficacy of AT-1501 compared with t...
Status
Completed
Location
University of California Los Angeles
Start Date
2023-08-30
Trial ID
NCT05983770
Treatments Being Tested
This study will evaluate the long term safety and efficacy of AT-1501 (tego...
Status
Enrolling By Invitation
Location
University of California Los Angeles
Start Date
2023-10-25
Trial ID
NCT06126380
Treatments Being Tested
This study will evaluate the safety, PK, and efficacy of AT 1501 in patient...
Status
Recruiting
Location
University of Cincinnati
Start Date
2022-02-18
Trial ID
NCT05027906
Treatments Being Tested
Tegoprubart (AT-1501) is a monoclonal antibody. Antibodies are Y-shaped pro...
Status
Active Not Recruiting
Location
University of Chicago
Start Date
2024-03-04
Trial ID
NCT06305286
Treatments Being Tested